Related references
Note: Only part of the references are listed.Sustained-release nanoART formulation for the treatment of neuroAIDS
Rahul Dev Jayant et al.
International Journal of Nanomedicine (2015)
The role of reactive oxygen species in morphine addiction of SH-SY5Y cells
Jun Ma et al.
LIFE SCIENCES (2015)
Creatine Protects Against Mitochondrial Dysfunction Associated with HIV-1 Tat-Induced Neuronal Injury
Patrick R. Stevens et al.
CURRENT HIV RESEARCH (2014)
HIV-1 Tat C phosphorylates VE-cadherin complex and increases human brain microvascular endothelial cell permeability
Ritu Mishra et al.
BMC NEUROSCIENCE (2014)
HIV increases the release of dickkopf-1 protein from human astrocytes by a Cx43 hemichannel-dependent mechanism
Juan Andres Orellana et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation
Tamima Ashraf et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Enhanced blood-brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation
Hong Ding et al.
NANOTECHNOLOGY (2014)
Towards nanomedicines for neuroAIDS
Vidya Sagar et al.
REVIEWS IN MEDICAL VIROLOGY (2014)
Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder
Venkata Subba Rao Atluri et al.
MOLECULAR BRAIN (2014)
Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival
Adriano Ferrucci et al.
JOURNAL OF NEUROVIROLOGY (2013)
Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro Study
Sudheesh Pilakka-Kanthikeel et al.
PLOS ONE (2013)
Human Synaptic Plasticity Gene Expression Profile and Dendritic Spine Density Changes in HIV-Infected Human CNS Cells: Role in HIV-Associated Neurocognitive Disorders (HAND)
Venkata Subba Rao Atluri et al.
PLOS ONE (2013)
Magneto-electric Nanoparticles to Enable Field-controlled High-Specificity Drug Delivery to Eradicate Ovarian Cancer Cells
Rakesh Guduru et al.
SCIENTIFIC REPORTS (2013)
HIV-1 Tat protein increases the permeability of brain endothelial cells by both inhibiting occludin expression and cleaving occludin via matrix metalloproteinase-9
Ruifen Xu et al.
BRAIN RESEARCH (2012)
HIV-1 Nef: a multifaceted modulator of T cell receptor signaling
Libin Abraham et al.
CELL COMMUNICATION AND SIGNALING (2012)
Anti-HIV-1 nanotherapeutics: promises and challenges for the future
Supriya D. Mahajan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Infection of human pericytes by HIV-1 disrupts the integrity of the blood-brain barrier
Shinsuke Nakagawa et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions
Servio H. Ramirez et al.
JOURNAL OF NEUROSCIENCE (2012)
HIV-1 Tat Triggers Nuclear Localization of ZO-1 via Rho Signaling and cAMP Response Element-Binding Protein Activation
Yu Zhong et al.
JOURNAL OF NEUROSCIENCE (2012)
An inverted blood-brain barrier model that permits interactions between glia and inflammatory stimuli
Hope A. Sansing et al.
JOURNAL OF NEUROSCIENCE METHODS (2012)
Human Immunodeficiency Virus-1 Uses the Mannose-6-Phosphate Receptor to Cross the Blood-Brain Barrier
Shinya Dohgu et al.
PLOS ONE (2012)
HIV-1 Nef interferes with T-lymphocyte circulation through confined environments in vivo
Bettina Stolp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Blood-Brain Barrier Abnormalities Caused by HIV-1 gp120: Mechanistic and Therapeutic Implications
Jean-Pierre Louboutin et al.
SCIENTIFIC WORLD JOURNAL (2012)
Slit2/Robo4 Signaling Modulates HIV-1 gp120-Induced Lymphatic Hyperpermeability
Xuefeng Zhang et al.
PLOS PATHOGENS (2012)
Human Immunodeficiency Virus Infection of Human Astrocytes Disrupts Blood-Brain Barrier Integrity by a Gap Junction-Dependent Mechanism
Eliseo A. Eugenin et al.
JOURNAL OF NEUROSCIENCE (2011)
Nanotechnology applications for improved delivery of antiretroviral drugs to the brain
Ho Lun Wong et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
HIV-associated neurocognitive disorders: is there a hidden epidemic?
Justin C. McArthur et al.
AIDS (2010)
Magnetic nanoformulation of azidothymidine 5’-triphosphate for targeted delivery across the blood–brain barrier
Nair et al.
International Journal of Nanomedicine (2010)
HIV-1 gp120-Induced Injury to the Blood-Brain Barrier: Role of Metalloproteinases 2 and 9 and Relationship to Oxidative Stress
Jean-Pierre Louboutin et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Extensive Astrocyte Infection Is Prominent in Human Immunodeficiency Virus-Associated Dementia
Melissa J. Churchill et al.
ANNALS OF NEUROLOGY (2009)
The blood-brain barrier in brain homeostasis and neurological diseases
Nicolas Weiss et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Elodie Boisselier et al.
CHEMICAL SOCIETY REVIEWS (2009)
PPARα and PPARγ attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities
Wen Huang et al.
FASEB JOURNAL (2009)
Association of FAK activation with lentivirus-induced disruption of blood-brain barrier tight junction-associated ZO-1 protein organization
Nathan S. Ivey et al.
JOURNAL OF NEUROVIROLOGY (2009)
NanoART, neuroAIDS and CNS drug delivery
Ari Nowacek et al.
NANOMEDICINE (2009)
Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system
Scott Letendre et al.
ARCHIVES OF NEUROLOGY (2008)
Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and-2 in human brain microvascular endothelial cells
Shinichi Nakamuta et al.
JOURNAL OF NEUROVIROLOGY (2008)
Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes
Eliseo A. Eugenin et al.
JOURNAL OF NEUROSCIENCE (2007)
Glial regulation of the cerebral microvasculature
Costantino Iadecola et al.
NATURE NEUROSCIENCE (2007)
Herpes simplex virus-type 2 infectivity and agents that block gap junctional intercellular communication
Maureen T. Knabb et al.
VIRUS RESEARCH (2007)
HIV-1 gp120 compromises blood-brain barrier integrity and enhance monocyte migration across blood-brain barrier: implication for viral neuropathogenesis
Georgette D Kanmogne et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE)
Yuri Persidsky et al.
BLOOD (2006)
CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: A potential mechanism of HIV-CNS invasion and NeuroAIDS
EA Eugenin et al.
JOURNAL OF NEUROSCIENCE (2006)
HIV-1 Tat protein-induced alterations of ZO-1 expression are mediated by redox-regulated ERK1/2 activation
H Pu et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: Implications for the pathogenesis of HIV-associated dementia
GD Kanmogne et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
The blood-brain barrier/neurovascular unit in health and disease
BT Hawkins et al.
PHARMACOLOGICAL REVIEWS (2005)
Influence of HAART on HIV-related CNS disease and neuroinflammation
IC Anthony et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells
TO Price et al.
BRAIN RESEARCH (2005)
Permeability of the blood-brain barrier to HIV-1 Tat
WA Banks et al.
EXPERIMENTAL NEUROLOGY (2005)
Human immunodeficiency virus type 1 Nef potently induces a in primary human brain microvascular endothelial cells via the activation of caspases
EA Acheampong et al.
JOURNAL OF VIROLOGY (2005)
HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: Possible role in NeuroAIDS
EA Eugenin et al.
GLIA (2005)
Mechanisms of the blood-brain barrier disruption in HIV-1 infection
M Toborek et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2005)
The neuropathogenesis of AIDS
F Gonzalez-Scarano et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Effects of neuroinflammation on glia-glia gap junctional intercellular communication: a perspective
T Kielian et al.
NEUROCHEMISTRY INTERNATIONAL (2004)
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion
MD Bobardt et al.
JOURNAL OF VIROLOGY (2004)
The blood-brain barrier: an overview - Structure, regulation, and clinical implications
P Ballabh et al.
NEUROBIOLOGY OF DISEASE (2004)
Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts
EG Argyris et al.
JOURNAL OF VIROLOGY (2003)
Plasma membrane channels formed by connexins:: Their regulation and functions
JC Sáez et al.
PHYSIOLOGICAL REVIEWS (2003)
Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection
Y Persidsky et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Gap junctions and connexin expression in the normal and pathological central nervous system
N Rouach et al.
BIOLOGY OF THE CELL (2002)
Circulating gp120 alters the blood-brain barrier permeability in HIV-1 gp120 transgenic mice
C Cioni et al.
NEUROSCIENCE LETTERS (2002)
Astrocyte-endothelial interactions and blood-brain barrier permeability
NJ Abbott
JOURNAL OF ANATOMY (2002)
HIV-1 Vpr transactivates LTR-directed expression through sequences present within-278 to-176 and increases virus replication in vitro
R Vanitharani et al.
VIROLOGY (2001)
Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands
Y Liu et al.
NATURE MEDICINE (2000)
Blood-brain barrier disruption in simian immunodeficiency virus encephalitis
MK Luabeya et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2000)
Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9
B Sporer et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Share Paper
